Latest Close
₹567.85
-10.20%
Connecting…
Day Range
-
Full OHLC pending
Volume
-
Full session data pending
50 DMA
₹686.72
200 DMA
₹667.50
1 year gain / loss
−₹129.65(-18.59%)
₹697.50 → ₹567.85· 2025-10-30 to 2026-10-30
Charting by TradingView
This stock does not satisfy the default swing-support rules at the selected chart endpoint. Its price, volume and moving averages remain available for manual research.
Snapshot 2026-11-02 · Financial period Sep 2026 · Consolidated figures where available
Jubilant Ingrevia Limited is a vertically integrated provider of life sciences products and solutions. Its segments include Specialty chemicals, Nutrition & Health solutions and Chemical intermediates. The Specialty Chemicals segment includes bio-pyridine & bio-picolines, fine chemicals, agro chemicals, custom development and manufacturing organization, and microbial control solutions. The Nutrition & Health solutions segment includes nutrition and health ingredients and animal and human nutrition health solutions. The Chemical Intermediates segment includes acetyls and specialty ethanol. In agro chemicals, it offers value-added derivatives, derived from specialty building blocks such as pyridine, picoline and diketene derivatives. This sub-segment includes insecticides, herbicides and fungicides. Its product portfolio includes vital nutritional ingredients, including Vitamin B3, Vitamin B4, Picolinates, and premix formulations designed for both animal and human nutrition.
Market Cap
₹9,122.83 Cr
P/E
25.40×
Sector 23.06× · above
P/B
2.68×
Sector 2.73× · below
EV / EBITDA
13.21×
Sector 3.44× · above
ROE
10.57%
Sector -1.34%
ROCE
12.22%
Sector 69.55%
ROA
5.84%
Sector 54.01%
Cash Flow / Profit
1.89×
| Period | Revenue | Operating profit | Net profit |
|---|---|---|---|
| Sep 2026 | 1,403.26 +7.1% | 147.98 | 111.43 +5.3% |
| Jun 2026 | 1,310.49 +10.3% | 140.86 | 105.82 +22.4% |
| Mar 2026 | 1,187.96 +12.0% | 111.71 | 86.44 +84.3% |
| Dec 2025 | 1,060.41 | 65.41 | 46.9 |
Dividend
24 Jul 2026 · ₹2.5
Dividend
10 Feb 2026 · ₹2.5